Trupanion Third Quarter 2026 Earnings Call - TRUPANION INC

Financial Performance:

• Total revenue reached $405.6 million in Q3 2026, an 11% year-over-year increase; subscription revenue was $287.9 million (up 14% YoY).
• Adjusted operating income (AOI) hit an all-time high of $47.4 million, up 15% YoY; subscription AOI was $45.4 million with a margin of 15.8%.
• Net income was $9.3 million ($0.21 per share), marking the sixth consecutive quarter of profitability.
• Free cash flow reached $28.5 million, an all-time high, with 10 consecutive quarters of positive FCF.
• Operating cash flow was $30.7 million; capital expenditures were $2.2 million.
• Balance sheet strength: $396.8 million in cash and short-term investments; total debt reduced to $104.5 million (down $10.1 million YoY).
• Value proposition (cost of veterinary invoices vs. subscription revenue) was 69.7%, down slightly from 70.1% YoY, despite $0.6 million in adverse prior period development.

Guidance and Future Outlook:

• Full-year 2026 total revenue guidance raised to $1.59 billion–$1.597 billion; subscription revenue guidance narrowed to $1.131 billion–$1.133 billion (midpoint +14% growth).
• Full-year 2026 adjusted operating income guidance raised to $179 million–$182 million (midpoint +19% growth).
• Q4 2026 total revenue expected to be $407 million–$414 million; subscription revenue $297 million–$299 million; AOI expected at $48 million–$51 million.
• Long-term strategic goals include launching a new digital offering mid-2027 and the Landspath pet food initiative in 2027.
• Management expects double-digit inflation in veterinary costs to persist through 2027, though annual premium rate increases are anticipated to ease as the book adjusts.

Business Segments and Product Lines:

• Subscription business remains the primary growth driver, adding 20,500 net new pets (up 28% YoY) and increasing retention for the seventh consecutive quarter (98.38% average).
• New pet acquisition cost averaged $279 per pet, down from $290 YoY, driven by improved conversion rates and efficiency.
• "Other business" segment revenue decreased 3% YoY to $117.7 million due to the ongoing transition of the PetsFest book of business.
• Product expansion: Co-insurance and deductible options now available to 90% of US and 100% of Canadian members, boosting conversion.
• Landspath (pet food) initiated limited trials; full commercial launch targeted for mid-2027 via veterinary partners.
• New digital product under development, expected to launch mid-2027 based on learnings from the core product's flexibility rollout.

Market and Competitive Landscape:

• Total market opportunity remains vast with only ~7 million insured pets out of 180 million in the US and Canada.
• Trupanion leads the North American market with a unique "pay-at-checkout" software integration used by the most veterinary clinics in five years.
• Claims automation rate increased from <15% in 2020 to >65% today, creating a durable operational moat and enhancing speed.
• Strategic brand partnerships, including with Simon Cowell, are driving category awareness and targeting pet parents earlier in the lifecycle.
• Market penetration is accelerating as veterinary cost pressures on pet parents increase demand for insurance solutions.

Risks and Challenges:

• Persistent double-digit inflation in veterinary costs is expected to continue into 2027, requiring ongoing pricing adjustments.
• Execution risks associated with launching new product lines (digital offering, Landspath) and integrating them into existing veterinary workflows.
• Dependency on third-party veterinary clinics for lead generation and point-of-sale integration, though relationships are deepening.
• Forward-looking statements involve risks related to economic conditions, veterinary industry trends, and potential deviations in claims experience.

Management Commentary and Tone:

• Tone was highly confident and positive, emphasizing "momentum," "all-time highs," and "disciplined execution."
• Management highlighted the successful balance between aggressive growth investments (highest ever in pet acquisition spend) and profitability.
• Strong emphasis on the "durable moat" created by proprietary technology, automation, and direct payments at veterinary checkouts.
• Leadership expressed pride in reaching record lifetime value and contribution per pet while honoring value propositions.

Analyst Questions and Answers:

• Conversion Drivers: Management attributed improved conversion to the rollout of flexible co-insurance/deductible options and UX/AI enhancements on the enrollment journey, not just paid campaigns.
• Retension Trends: Retention improved for the 7th straight quarter; first-year retention is seeing early benefits from the new product flexibility despite typical cohort headwinds.
• Capital Allocation: The $25 million share repurchase was opportunistic; subsequent to quarter-end, $15 million in debt was repaid, leaving $18.5 million available under the credit facility.
• Food Business (Landspath): Timeline is mid-2027; focus is on vet workflow integration and logistics validation before scaling.
• AI and Leads: Management sees AI (specifically agentic search) as a strong channel for conversion due to Trupanion's transparent value proposition, which traditional search lacks.
• Inflation Outlook: Costs expected to remain in double-digit inflation for 2027, but rate increases are projected to moderate as the book adjusts, potentially aiding retention.

Other Key Points:

• Investor Day scheduled for March 1st in New York to present further strategic plans.
• Trupanion's PetsFest agreement is ending after Q3 2028; transition to a new underwriting partner begins in Q4 2026.
• Stock-based compensation expense was $7.9 million for the quarter.
• The company continues to view itself as a "growth company" with significant capital flexibility to fund organic growth and return capital to shareholders.